Mallinckrodt Institute of Radiology
Welcome,         Profile    Billing    Logout  
 6 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dehdashti, Farrokh
NCT04271436: Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

Recruiting
2
30
US
FDG PET/CT, FLT PET/CT, PET/MR, [F-18] flurothymidine
Washington University School of Medicine
Cancer
01/25
01/25
NCT02398773: FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

Active, not recruiting
2
99
US
Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, F-18 16 Alpha-Fluoroestradiol, 16 alpha-fluroestradiol-17 beta, F-18 FES, FES, Fluorine-18 16 alpha-fluoroestradiol, Fluoroestradiol F-18, Laboratory Biomarker Analysis, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
National Cancer Institute (NCI)
HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7
04/25
04/25
NCT06179303: Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Suspended
2
60
US
Abemaciclib, LY-2835219, LY2835219, Verzenio, Anastrozole, Anastrazole, Arimidex, ICI D1033, ICI-D1033, ZD-1033, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Diagnostic Imaging, Medical Imaging, Exemestane, Aromasin, FCE-24304, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Fluorine F 18 Fluoro Furanyl Norprogesterone, [18F]FFNP, Fulvestrant, Faslodex, Faslodex(ICI 182,780), ICI 182,780, ICI 182780, ZD9238, Gonadotropin-releasing Hormone Analog, GnRH Agonist, GnRH Analog, Gonadotropin-Releasing Hormone Agonist, Gonadotropin-Releasing Hormone Analogue, LH-RH agonist, LH-RH Analogs, LHRH Agonist, luteinizing hormone-releasing hormone agonist, Luteinizing Hormone-Releasing Hormone Analog, Letrozole, CGS 20267, Femara, Fempro, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Tamoxifen, TMX, Therapeutic Estradiol, 17 Beta-Estradiol, Aquadiol, Climara, Dimenformon, Diogyn, Diogynets, Estrace, ESTRADIOL, Estraldine, Oestradiol, Ovocylin, Progynon, Vagifem
University of Washington, Breast Cancer Research Foundation
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable HER2-Negative Breast Carcinoma, Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma
03/25
06/26
NCT05226663: A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer

Suspended
2
36
US
Computed Tomography, CAT, CAT Scan, Computerized Axial Tomography, Computerized Tomography, CT, CT Scan, tomography, Fluorine F 18 Fluorthanatrace, [18F]FluorThanatrace, [18F]FTT, FLUORTHANATRACE F-18, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging
M.D. Anderson Cancer Center, National Cancer Institute (NCI), Trevarx Biomedical, Inc
Breast Carcinoma
08/26
08/26
NCT02469129: PET Imaging of PARP Activity in Cancer

Active, not recruiting
1
50
US
[18F]FluorThanatrace, [18F]FTT
Washington University School of Medicine
Cancer
07/24
07/25
NCT05048732: Imaging Apoptosis for Lymphoma Treatment Response

Terminated
1
12
US
18F-FluorApoTrace, 18F-FAT
Washington University School of Medicine, AbbVie
Diffuse Large B Cell Lymphoma
02/24
02/24
NCT03804424: 64Cu-LLP2A for Imaging Multiple Myeloma

Terminated
1
10
US
64Cu-LLP2A, PET/MR, Blood samples for serum stability, Blood samples for metabolite analysis, Urine sample, Tumor biopsy, Electrocardiogram, ECG, PET/CT
Washington University School of Medicine
Multiple Myeloma
10/21
10/21
NCT06636175: 64Cu-LLP2A for Imaging Hematologic Malignancies

Not yet recruiting
1
42
US
64Cu-LLP2A, PET/CT
Washington University School of Medicine
Multiple Myeloma, Low-Grade Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Lymphoplasmacytic Lymphoma, Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia
12/26
12/26
NCT04217057: Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer

Terminated
1
11
US
64Cu-DOTA-ECL1i
Washington University School of Medicine, National Institutes of Health (NIH), National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Head and Neck Cancer
02/23
02/23
NCT03851237: CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Recruiting
1
75
US
64Cu-DOTA-ECLIi, PET/CT
Washington University School of Medicine, National Cancer Institute (NCI)
Pancreatic Ductal Adenocarcinoma
06/25
06/25
NCT05513027: Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

Recruiting
N/A
35
US
Augmented Whole-body Scanning via Magnifying PET, AWSM-PET, PET/CT
Washington University School of Medicine, National Cancer Institute (NCI)
Cancer
05/27
05/27

Download Options